The results revealed that the expression of E-cadherin was decreased (Figures 1K, L-a), while that of vimentin was increased in LoVo and Hct116 cells after ATO treatment compared to that of E-cadherin and vimentin in control cancer cells (Figures 1K, L-b). The gene discussed is VIM; the disease is cancer.